# Use of 18F-PSMA-11 PET for Detection of Lesions in Iodine Refractory Thyroid Cancers

> **NCT05175404** · PHASE2 · COMPLETED · sponsor: **University Hospital, Ghent** · enrollment: 8 (actual)

## Conditions studied

- Thyroid Cancer

## Interventions

- **DIAGNOSTIC_TEST:** PET/CT scan F18-PSMA-11

## Key facts

- **NCT ID:** NCT05175404
- **Lead sponsor:** University Hospital, Ghent
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-24
- **Primary completion:** 2023-07-18
- **Final completion:** 2023-07-18
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2025-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05175404

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05175404, "Use of 18F-PSMA-11 PET for Detection of Lesions in Iodine Refractory Thyroid Cancers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05175404. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*